PRODH c.854_855insA ;(p.S285Rfs*12)

Variant ID: 22-18909912-A-AT

NM_016335.4(PRODH):c.854_855insA;(p.S285Rfs*12)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors.

Theranostics
Shi, Zhiwen Z; Shen, Jianfeng J; Qiu, Junjun J; Zhao, Qingguo Q; Hua, Keqin K; Wang, Hongyan H
Publication Date: 2021

Variant appearance in text: PRODH: 854_854insA; S285fs
PubMed Link: 34158843
Variant Present in the following documents:
  • thnov11p7175s3.xlsx, sheet 1
View BVdb publication page